Marshall Wace, LLP Cassava Sciences Inc Transaction History

Marshall Wace, LLP

  • $78.4 Billion
  • Q4 2024

A detailed history of Marshall Wace, LLP transactions in Cassava Sciences Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 21,093 shares of SAVA stock, worth $52,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,093
Holding current value
$52,310
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$2.29 - $32.18 $48,302 - $678,772
21,093 New
21,093 $49,000
Q2 2023

Aug 14, 2023
BUY
$21.59 - $27.88 $525,673 - $678,822
24,348 New
24,348 $597,000
Q3 2022

Nov 14, 2022
BUY
$16.33 - $51.06 $2.57 Million - $8.03 Million
157,325 New
157,325 $6.58 Million
Q2 2021

Aug 13, 2021
SELL
$32.15 - $89.72 $6.3 Million - $17.6 Million
-195,942 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$7.09 - $87.95 $1.5 Million - $18.6 Million
-211,864 Reduced 51.95%
195,942 $8.81 Million
Q4 2020

Feb 16, 2021
BUY
$6.79 - $12.25 $2.63 Million - $4.75 Million
387,866 Added 1945.17%
407,806 $2.78 Million
Q3 2020

Nov 16, 2020
BUY
$2.86 - $11.51 $57,028 - $229,509
19,940 New
19,940 $230,000
Q1 2020

May 15, 2020
SELL
$3.26 - $9.65 $178,220 - $527,555
-54,669 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.1 - $6.12 $60,135 - $334,574
54,669 New
54,669 $284,000

Others Institutions Holding SAVA

# of Institutions
190
Shares Held
16.4M
Call Options Held
3.49M
Put Options Held
8.08M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $99.4M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email